A clinical trial update was recorded on October 15, 2026, for a study involving diroximel fumarate (Vumerity). The trial, registered as NCT05688436, is titled "A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies." According to the posted record, the study's current status is active, not recruiting. No phase designation was listed for this study in the available data. The trial is designed to examine safety information related to diroximel fumarate use during pregnancy and outcomes for infants of participants who took the medication. No results have been posted as part of this update. This status reflects only that the study is ongoing and is no longer enrolling new participants. No efficacy or safety conclusions are stated in this update, and none should be inferred from the status change alone. Readers interested in general background on diroximel fumarate and its related compound glatiramer can consult the compound overview for additional context.
Diroximel Fumarate Pregnancy Safety Study Update: Active, Not Recruiting
See the full glatiramer overview
Source: https://clinicaltrials.gov/study/NCT05688436